{"anticipatedPostingDate":"2031-06","denomUnitsSelected":"Participants","description":"Disease-free survival is the time from start of treatment to documented evidence of disease progression measured by the following response criteria. Progressive disease ≥50% increase in sum of products of perpendicular diameters of evaluable (\\> 2cm) lymphadenopathy or appearance of new evaluable lymph nodes \\>2cm.","reportingStatus":"NOT_POSTED","timeFrame":"time from start of treatment to documented evidence of disease progression","title":"Disease-free Survival (DFS)","type":"SECONDARY"}